Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × Methods × 30 days × Clear all

Sponsor

Conditions

Skin Carcinoma 2 Pain 2 Neoplasms 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Tobacco Smoking 1 Smoking Cessation 1 Smoking 1 Sepsis 1 Papillomavirus Infections 1 Neoplasm Metastasis 1 Lymphoma 1 Inflammatory Breast Neoplasms 1 Hematologic Neoplasms 1 Frailty 1 Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1 Cigarette Smoking 1 Chemotherapy-Induced Peripheral Neuropathy 1 Behavior, Addictive 1 Alzheimer Disease 1 Agnosia 1

Interventions

Carboplatin 4 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 pembrolizumab 2 fludarabine phosphate 2 Taxes 2 Radiotherapy 2 Radiation 2 Paclitaxel 2 Cyclophosphamide 2 Biopsy 2 veliparib 1 methoxyamine 1 fludarabine 1 durvalumab 1 dapagliflozin 1 capmatinib 1 aldesleukin 1 Standard of Care 1 Smoking Devices 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Radiosurgery 1 Practice Guidelines as Topic 1 Platinum 1 Pemetrexed 1 Nivolumab 1 Ipilimumab 1 Interleukin-2 1 Interleukin-13 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡